BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 9:25:00 AM | Browse: 935 | Download: 1053
 |
Received |
|
2013-06-28 11:23 |
|
Peer-Review Started |
|
2013-06-28 17:28 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-07-19 22:14 |
|
Revised |
|
2013-08-26 22:43 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2013-10-16 09:13 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2013-10-16 10:32 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2013-12-30 17:04 |
|
Publish the Manuscript Online |
|
2013-12-31 17:17 |
| Category |
Transplantation |
| Manuscript Type |
Review |
| Article Title |
Novel immunosuppressive agents in kidney transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Karen L Hardinger and Daniel C Brennan |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Karen L Hardinger, PharmD, BCPS, Clinical Associate Professor of Pharmacy Practice, Department of Pharmacy Practice and Administration, University of Missouri-Kansas City, 2464 Charlotte Street, Rm 2241, Kansas City, MO 64108, United States. hardingerk@umkc.edu |
| Key Words |
Review; Immunosuppression; Investigational agents; Renal/kidney transplant |
| Core Tip |
Core tip: Many new agents are being studied that may improve outcomes after renal transplantation. Potential improvements to the calcineurin inhibitor class include a recently Food and Drug Administration approved, prolonged release tacrolimus formulation and voclosporin, a cyclosporine analog. A novel, fully-human anti-CD40 monoclonal antibody, ASKP1240, is currently enrolling patients in phase 2 trials with calcineurin minimization and avoidance regimens. Novel treatments for antibody mediated rejection include bortezomib and eculizumab. |
| Publish Date |
2013-12-31 17:17 |
| Citation |
Hardinger KL, Brennan DC. Novel immunosuppressive agents in kidney transplantation. World J Transplant 2013; 3(4): 68-77 |
| URL |
http://www.wjgnet.com/2220-3230/full/v3/i4/68.htm |
| DOI |
http://dx.doi.org/10.5500/wjt.v3.i4.68 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
